Options: Show MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic gastritis | x | x | ||||||||||||
| Duodenal ulcer | x | x | x | x | x | x | x | x | x | x | x | x | ||
| Gastric ulcer | x | x | x | x | x | x | ||||||||
| Gastrooesophageal reflux disease | x | x | x | x | x | x | x | x | x | x | x | x | ||
| Heartburn | x | x | x | x | x | x | x | x | x | x | ||||
| Infection | x | x | x | x | x | x | x | |||||||
| Non-erosive reflux disease | x | x | x | x | ||||||||||
| Peptic ulcer | x | x | ||||||||||||
| Regurgitation | x | x | x | x | ||||||||||
| Ulcer | x | x | x | x | x | x | x | x | x | x | x | x | ||
| Zollinger-Ellison syndrome | x | x | x | x | x | x | x | x | x | x | ||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |